MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash received from
customers
$2,656,400K
Dividend proceeds and
miscellaneous receipts, net
$81,000K
Net cash provided by
operating activities
$532,200K
Canceled cashflow
$2,205,200K
Net increase
(decrease) in cash, cash...
$42,400K
Canceled cashflow
$489,800K
Cash paid to
suppliers and employees
$2,058,900K
Income tax payments,
net
$61,600K
Interest paid, net
$46,600K
(payments for) proceeds
from forward foreign...
-$38,100K
Proceeds from issuance of
common stock and from...
$15,800K
Proceeds from sales of
marketable securities and...
$793,600K
Proceeds from maturities
of marketable...
$62,000K
Proceeds from
dispositions of property,...
$100K
Net cash used in
financing activities
-$283,200K
Net cash (used in)
provided by investing...
-$189,700K
Effect of foreign
exchange rate changes on...
-$16,900K
Canceled cashflow
$15,800K
Canceled cashflow
$855,700K
Payments for purchases of
treasury stock
$295,500K
Payments for purchases of
marketable securities and...
$669,300K
Tax payments from
net share...
$3,000K
Payments on long-term
debt
$500K
Payments for business
acquisitions, net of cash...
$218,500K
Payments for purchases of
property, plant and...
$157,600K
Back
Back
Cash Flow
source: myfinsight.com
BIO-RAD LABORATORIES, INC. (BIO-B)
BIO-RAD LABORATORIES, INC. (BIO-B)